Cargando…
Optical Imaging for Monitoring Tumor Oxygenation Response after Initiation of Single-Agent Bevacizumab followed by Cytotoxic Chemotherapy in Breast Cancer Patients
PURPOSE: Optical imaging techniques for measuring tissue hemoglobin concentration have been recently accepted as a way to assess tumor vascularity and oxygenation. We investigated the correlation between early optical response to single-agent bevacizumab and treatment outcome. METHODS: Seven patient...
Autores principales: | Ueda, Shigeto, Kuji, Ichiei, Shigekawa, Takashi, Takeuchi, Hideki, Sano, Hiroshi, Hirokawa, Eiko, Shimada, Hiroko, Suzuki, Hiroaki, Oda, Motoki, Osaki, Akihiko, Saeki, Toshiaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4048242/ https://www.ncbi.nlm.nih.gov/pubmed/24905225 http://dx.doi.org/10.1371/journal.pone.0098715 |
Ejemplares similares
-
In vivo imaging of eribulin-induced reoxygenation in advanced breast cancer patients: a comparison to bevacizumab
por: Ueda, Shigeto, et al.
Publicado: (2016) -
Clinicopathological and prognostic impact of imaging of breast cancer angiogenesis and hypoxia using diffuse optical spectroscopy
por: Nakamiya, Noriko, et al.
Publicado: (2014) -
Optical imaging of tumor vascularity associated with proliferation and glucose metabolism in early breast cancer: clinical application of total hemoglobin measurements in the breast
por: Ueda, Shigeto, et al.
Publicado: (2013) -
Intracellular hypoxia measured by (18)F-fluoromisonidazole positron emission tomography has prognostic impact in patients with estrogen receptor-positive breast cancer
por: Asano, Aya, et al.
Publicado: (2018) -
Correction to: Intracellular hypoxia measured by F-18 fluoromisonidazole positron emission tomography has prognostic impact in patients with estrogen-receptor positive breast (BRCR-D17-00693)
por: Asano, Aya, et al.
Publicado: (2018)